These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1487679)

  • 1. The course of clinical COPD in Thailand.
    Charoenpan P; Kiatboonsri S; Saenghirunvattana S; Aursudkij B; Vathesatogkit P; Vongvitat K
    J Med Assoc Thai; 1992 Jun; 75(6):320-7. PubMed ID: 1487679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in forced expiratory time and spirometric performance during a single pulmonary function testing session.
    Tsai AG; Christie JD; Gaughan CA; Palma WR; Margolis ML
    Respir Care; 2006 Mar; 51(3):246-51. PubMed ID: 16533413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does bronchial hyperresponsiveness precede or follow airway obstruction in asthma or COPD?
    van Schayck CP; Dompeling E; Molema J; Folgering H; van Grunsven PM; van Weel C
    Neth J Med; 1994 Oct; 45(4):145-53. PubMed ID: 7808576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interpretation of the spirogram. How accurate is it for 'obstruction'?
    Gilbert R; Auchincloss JH
    Arch Intern Med; 1985 Sep; 145(9):1635-9. PubMed ID: 4026493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
    Zietkowski Z; Kucharewicz I; Bodzenta-Lukaszyk A
    Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
    Chhabra SK; Bhatnagar S
    Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
    Walker PP; Calverley PM
    COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spirometric indices after bronchodilator test in obstructive lung disease.
    Mehrparvar AH; Mirmohammadi SJ; Sohrabi MM
    Acta Med Iran; 2010; 48(4):226-30. PubMed ID: 21279934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of edentulism on spirometric values].
    Carossa S; Pera P; De Lillo A; Corsalini M; Lombardo S; Bucca C
    Minerva Stomatol; 2000 Sep; 49(9):405-8. PubMed ID: 11256200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical data discriminating between adults with positive and negative results on bronchodilator testing.
    Lehmann S; Bakke PS; Eide GE; Gulsvik A
    Int J Tuberc Lung Dis; 2008 Feb; 12(2):205-13. PubMed ID: 18230255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of bronchodilator response through changes in lung volumes in chronic airflow obstruction.
    Figueroa-Casas JB; Diez AR; Rondelli MP; Figueroa-Casas MP; Figueroa-Casas JC
    Medicina (B Aires); 2003; 63(5):377-82. PubMed ID: 14628645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.
    Hansen EF; Phanareth K; Laursen LC; Kok-Jensen A; Dirksen A
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1267-71. PubMed ID: 10194175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study].
    Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K
    Ugeskr Laeger; 2000 Jan; 162(4):493-7. PubMed ID: 10697447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes after single and bilateral lung transplantation for obstructive lung disease.
    Bando K; Paradis IL; Keenan RJ; Yousem SA; Komatsu K; Konishi H; Guilinger RA; Masciangelo TN; Pham SM; Armitage JM
    J Heart Lung Transplant; 1995; 14(4):692-8. PubMed ID: 7578177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilator response in chronic obstructive pulmonary disease.
    Anthonisen NR; Wright EC
    Am Rev Respir Dis; 1986 May; 133(5):814-9. PubMed ID: 3706890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.
    Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA
    Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.